<VariationArchive VariationID="369909" VariationName="NM_023067.4(FOXL2):c.353_476dup (p.His159fs)" VariationType="Duplication" Accession="VCV000369909" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2016-12-18" MostRecentSubmission="2016-12-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="354130" VariationID="369909">
      <GeneList>
        <Gene Symbol="FOXL2" FullName="forkhead box L2" GeneID="668" HGNC_ID="HGNC:1092" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="138944224" stop="138947137" display_start="138944224" display_stop="138947137" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="138663065" stop="138665981" display_start="138663065" display_stop="138665981" Strand="-" />
          </Location>
          <OMIM>605597</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXL2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXL2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_023067.4(FOXL2):c.353_476dup (p.His159fs)</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="138946246" stop="138946247" display_start="138946246" display_stop="138946247" variantLength="124" positionVCF="138946246" referenceAlleleVCF="G" alternateAlleleVCF="GTGCGCGGGCGGCGGCCGGAAGGGCCTCTTCATGCGGCGGCGGCGCCGGTAGTTGCCCTTCTCGAACATGTCTTCGCAGGCCGGGTCCAGCGTCCAGTAGTTGCCCTTGCGCTCGCCGCCGCCCT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="138665088" stop="138665089" display_start="138665088" display_stop="138665089" variantLength="124" positionVCF="138665088" referenceAlleleVCF="G" alternateAlleleVCF="GTGCGCGGGCGGCGGCCGGAAGGGCCTCTTCATGCGGCGGCGGCGCCGGTAGTTGCCCTTCTCGAACATGTCTTCGCAGGCCGGGTCCAGCGTCCAGTAGTTGCCCTTGCGCTCGCCGCCGCCCT" />
      </Location>
      <ProteinChange>H159fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1295" sequenceAccession="LRG_1295">
            <Expression>LRG_1295:g.5771_5894dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.138665089_138665212dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.138665089_138665212dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.138946247_138946370dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.138946247_138946370dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012454.1" sequenceAccession="NG_012454" sequenceVersion="1" change="g.5771_5894dup">
            <Expression>NG_012454.1:g.5771_5894dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029796.1" sequenceAccession="NG_029796" sequenceVersion="1" change="g.4014_4137dup">
            <Expression>NG_029796.1:g.4014_4137dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_023067.4" sequenceAccession="NM_023067" sequenceVersion="4" change="c.353_476dup" MANESelect="true">
            <Expression>NM_023067.4:c.353_476dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_075555.1" sequenceAccession="NP_075555" sequenceVersion="1" change="p.His159fs">
            <Expression>NP_075555.1:p.His159fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1295t1" sequenceAccession="LRG_1295t1">
            <Expression>LRG_1295t1:c.353_476dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1295p1" sequenceAccession="LRG_1295p1" change="p.His159fs">
            <Expression>LRG_1295p1:p.His159fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10654883" DB="ClinGen" />
        <XRef Type="rs" ID="1553752890" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_023067.4(FOXL2):c.353_476dup (p.His159fs) AND Blepharophimosis, ptosis, and epicanthus inversus syndrome" Accession="RCV000408885" Version="2">
        <ClassifiedConditionList TraitSetID="1337">
          <ClassifiedCondition DB="MedGen" ID="C0220663">Blepharophimosis, ptosis, and epicanthus inversus syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-11-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-11-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-12-18" MostRecentSubmission="2016-12-18">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1337" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4679" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, and epicanthus inversus</ElementValue>
                <XRef ID="Blepharophimosis%2C+ptosis%2C+and+epicanthus+inversus/7828" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Blepharophimosis, ptosis, and epicanthus inversus syndrome</ElementValue>
                <XRef ID="3351" DB="GeneTests" />
                <XRef ID="MONDO:0007201" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BPES</ElementValue>
                <XRef Type="MIM" ID="110100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) is defined by a complex eyelid malformation characterized by four major features, all present at birth: blepharophimosis, ptosis, epicanthus inversus, and telecanthus. BPES type I includes the four major features and primary ovarian insufficiency; BPES type II includes only the four major features. Other ophthalmic manifestations that can be associated with BPES include dysplastic eyelids, lacrimal duct anomalies, strabismus, refractive errors, and amblyopia. Other craniofacial features may include a broad nasal bridge and low-set ears.</Attribute>
                <XRef ID="NBK1441" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="23" />
                <XRef ID="23" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301614</ID>
                <ID Source="BookShelf">NBK1441</ID>
              </Citation>
              <XRef ID="126" DB="Orphanet" />
              <XRef ID="C0220663" DB="MedGen" />
              <XRef ID="MONDO:0007201" DB="MONDO" />
              <XRef Type="MIM" ID="110100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="948339" SubmissionDate="2016-12-14" DateLastUpdated="2016-12-18" DateCreated="2016-12-18">
        <ClinVarSubmissionID localKey="FOXL2-24|OMIM:110100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000484866" DateUpdated="2016-12-18" DateCreated="2016-12-18" Type="SCV" Version="1" SubmitterName="Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia" OrgID="165021" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">DGD Variant Analysis Guidelines</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx</URL>
            <CitationText>DGD_Variant_Analysis_Guidelines.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.[His159Glnfs*121]</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_023067.3:c.353_476dup124</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="110100" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyDescription>Clinical Testing</StudyDescription>
        <Comment>Clinical Testing</Comment>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="948339" TraitType="Disease" MappingType="XRef" MappingValue="110100" MappingRef="OMIM">
        <MedGen CUI="C0220663" Name="Blepharophimosis, ptosis, and epicanthus inversus syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

